However, the miR-200b mimic in HG+MM could significantly downregulate the viability of RECs (0.95 ± 0.15 vs. 1.22 ± 0.10, p < 0.01) (Figure 3A) and the VEGFA mRNA and protein levels [0.94 ± 0.16 vs. 2.19 ± 0.58 (p < 0.01) and 1.59 ± 0.13 vs. 3.70 ± 0.35 (p < 0.01) respectively] (Figures 3B, C), but upregulated the miR-200b expression (4.91 ± 1.00 vs. 0.45 ± 0.18, p < 0.01) (Figure 3B) compared with HG. The gene discussed is VEGFA; the disease is Miyoshi myopathy.